Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

US IDE Study of the Contour NEurovasCular System™ for IntraCranial Aneurysm Repair

NCT: NCT04852783 · ACTIVE_NOT_RECRUITING

NCT IDNCT04852783
StatusACTIVE_NOT_RECRUITING
Start Date2021-08-06
Completion2030-02

Brief Summary

The purpose of this trial is to gather data on the safety and effectiveness of the Contour /Contour 021 System in the treatment of wide-necked bifurcated saccular, intracranial aneurysms for submission to FDA in support of a premarket approval application for the device.

Frequently Asked Questions

What is US IDE Study of the Contour NEurovasCular System™ for IntraCranial Aneurysm Repair?

US IDE Study of the Contour NEurovasCular System™ for IntraCranial Aneurysm Repair is a clinical trial registered under NCT04852783. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04852783?

The current status of NCT04852783 (US IDE Study of the Contour NEurovasCular System™ for IntraCranial Aneurysm Repair) is: ACTIVE_NOT_RECRUITING.

When did US IDE Study of the Contour NEurovasCular System™ for IntraCranial Aneurysm Repair start?

US IDE Study of the Contour NEurovasCular System™ for IntraCranial Aneurysm Repair started on 2021-08-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.